FDA-Approved rTMS Therapy in Kochi
Non-invasive brain stimulation for depression, OCD, and anxiety when medication alone hasn't worked.
A Targeted Neurological Pathway to Recovery
Around 30% of patients with depression do not respond adequately to standard medications. The same is true for many cases of OCD and anxiety. For decades, the only escalation option was more medication, higher doses, or invasive procedures like ECT.
Repetitive Transcranial Magnetic Stimulation (rTMS) changed that. It is an FDA-approved, non-invasive, non-systemic treatment that uses focused magnetic pulses to stimulate specific brain regions associated with mood and behavioral regulation. No anesthesia, no sedation, no memory effects, no systemic side effects.
Conditions We Treat with rTMS
Treatment-resistant depression
The strongest evidence base. Clinical response rates are around 50–70% for patients who have not responded to two or more antidepressant trials.
Obsessive-Compulsive Disorder (OCD)
Deep rTMS protocols specifically targeting the CSTC loop have FDA approval for OCD and show meaningful reductions in compulsive symptoms.
Generalized anxiety and panic
rTMS targeting right-frontal regions has growing evidence for reducing anxiety symptoms, especially where medication side effects are intolerable.
Smoking cessation and addiction cravings
Specific rTMS protocols are FDA-approved for smoking cessation and are emerging as adjuncts in alcohol and substance use treatment.
Post-stroke depression and cognitive symptoms
rTMS has growing evidence for mood and cognitive recovery after stroke or brain injury.
How rTMS Works
focused magnetic pulses pass painlessly through the skull to reactivate key brain networks.
Targeted stimulation
In depression, we target the left dorsolateral prefrontal cortex (DLPFC) — a region that is consistently underactive in depressed patients. Repeated stimulation gradually restores normal activity patterns.
Neuroplasticity activation
Repeated sessions over weeks induce long-term potentiation — strengthening underactive neural networks. Unlike medications, the changes persist after treatment ends.
Network-level effect
Although the coil targets a small surface region, the effect propagates through connected networks — reaching deeper limbic structures involved in mood and motivation.
No systemic exposure
Because rTMS acts locally on neural tissue, there is no systemic medication exposure. No weight gain, no sexual dysfunction, no sedation, no metabolic effects.
Our rTMS Treatment Protocol
Every step is clinically mapped, measured, and medically supervised.
Pre-treatment Assessment
Clinical evaluation by our psychiatrist to confirm suitability and screen for contraindications (metal implants, seizure history).
Motor Threshold Determination
Before treatment, we determine your individual stimulation intensity threshold to personalize dosage.
Treatment Sessions
Each session is 20–30 minutes. You sit comfortably, fully awake, reading or listening to music. Drive home immediately after.
Standard Course
Most protocols run 4–6 weeks, with sessions 5 days per week (20–30 sessions total). Progress is monitored using clinical scales.
Maintenance
After the acute course, some patients benefit from periodic maintenance sessions (e.g. monthly) to prevent relapse.
Why Choose MetroMind for rTMS
FDA-Approved Equipment
We use clinical-grade rTMS hardware operated by trained personnel — not consumer-grade or unverified devices.
qEEG-Guided Targeting
For complex cases, we use brain mapping to inform coil placement, improving the precision of stimulation.
Medical Supervision
Sessions are supervised by qualified clinical staff. Any side effects are managed immediately.
Integrated With Overall Care
rTMS is not a standalone service — it is integrated with your psychiatric care, medication, and therapy.
Frequently Asked Questions
Is rTMS painful?
No. Most patients describe rTMS as a tapping sensation on the scalp during the pulse. Some experience mild scalp discomfort or headache in the first few sessions, which typically resolves within a week. No anesthesia or sedation is required.
Is rTMS the same as ECT (electroconvulsive therapy)?
No. They are completely different treatments. ECT requires general anesthesia, induces a seizure, and can cause temporary memory effects. rTMS uses focused magnetic stimulation, requires no anesthesia, does not induce seizures, does not affect memory, and allows you to drive immediately afterward.
What is the success rate of rTMS for treatment-resistant depression?
Clinical studies show response rates of approximately 50–70% in patients who have not responded adequately to two or more antidepressants. Remission rates (full recovery) are typically 30–40%. Outcomes depend on individual factors.
What does rTMS therapy cost in Kochi?
Individual sessions typically range from ₹3,000–₹8,000 depending on protocol. A full course of 20–30 sessions represents a structured package. We provide transparent pricing during the pre-treatment consultation.
Can I continue my medication while doing rTMS?
Yes. rTMS is typically used as an add-on, not a replacement. Most patients continue their existing medications. Over time, depending on response, your psychiatrist may consider reducing medication dosage.
Are there side effects of rTMS?
The most common side effects are mild scalp discomfort and short-lived headache, especially in the first few sessions. Serious side effects are rare. The most significant rare risk is seizure — which is why we screen for contraindications carefully.
Who should not have rTMS?
rTMS is generally contraindicated for patients with metal implants near the head (excluding standard dental work), pacemakers, cochlear implants, or a history of seizure disorder.